InsightfulValue
← Home

Bachem Holding
Bachem Holding

Chemicals / Peptide and Biochemical Manufacturing Company


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Bachem Holding

πŸ“Š Get full analytics about Bachem Holding

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

Price
Live  
Overview
Bachem Holding AG is a leading global contract manufacturer and supplier of active pharmaceutical ingredients (APIs) and related services traditionally created through innovative chemistry both organic and biologic.
Founded in 1971, Bachem is headquartered in Bubendorf, Switzerland and has production sites in Switzerland, Germany, the UK, and the US. The company offers a comprehensive range of services that includes process development, custom synthesis, and manufacturing of APIs and intermediates for the pharmaceutical and biotechnology industries.
Bachem's mission is to provide its customers with high-quality products and services to support the development and manufacturing of life-saving and life-improving medicines. The company is committed to innovation, quality, and sustainability, and has a strong focus on customer satisfaction.
In addition to its manufacturing and development services, Bachem also offers a wide range of analytical services, including method development and validation, stability testing, and impurity identification.
Bachem's customers include some of the largest pharmaceutical companies in the world, as well as small biotech and start-up companies. The company's extensive experience and expertise in the production of complex molecules and peptides make it a trusted partner for drug development and manufacturing.
In 2020, Bachem reported sales of CHF 411.2 million and has a global workforce of approximately 1,500 employees. The company remains privately owned and is committed to sustainable growth and long-term success.
How to explain to a 10 year old kid about the company?
Bachem Holding is a company that makes special things called peptides, which are tiny building blocks made of proteins. Peptides are important for many things in our bodies, like helping our hormones and medicines work better.
Bachem makes these peptides for other companies that create medicines or do research in science. They work on making new medicines for diseases, helping people feel better. So, when Bachem sells these peptides to other companies, they make money.
The reason Bachem is successful is because they are really good at what they do. They have a lot of experience and use advanced technology to create high-quality peptides. They also have a good reputation, which means that other companies trust them and want to work with them.
In the future, Bachem is likely to stay successful because the demand for new medicines and scientific research keeps growing. As more people look for better treatments for different diseases, companies will need more peptides, and Bachem is in a great position to provide those. Plus, they are always improving their processes and products, which helps them stay ahead of the competition.

What is special about the company?
Bachem Holding

πŸ“ˆ Want to read more about Bachem Holding?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

QmFjaGVtIE hvbGRpbmcg aXMgYSBTd2 lzcyBjb21w YW55IHRoYX Qgc3BlY2lh bGl6ZXMgaW 4gdGhlIHBy b2R1Y3Rpb2 4gb2YgcGhh cm1hY2V1dG ljYWwgYW5k IGJpb2NoZW 1pY2FsIHBy b2R1Y3RzIH Rocm91Z2gg b3JnYW5pYy BzeW50aGVz aXMgYW5kIG Jpb3RlY2hu b2xvZ3kuIE l0IGlzIGNv bnNpZGVyZW QgYSBsZWFk ZXIgaW4gdG hlIHByb2R1 Y3Rpb24gb2 YgcGVwdGlk ZXMsIGFtaW 5vIGFjaWRz LCBhbmQgb3 RoZXIgY29t cGxleCBvcm dhbmljIG1v bGVjdWxlcy B1c2VkIGlu IHRoZSBkZX ZlbG9wbWVu dCBhbmQgcH JvZHVjdGlv biBvZiBkcn VncyBmb3Ig YSB3aWRlIH JhbmdlIG9m IG1lZGljYW wgY29uZGl0 aW9ucy48Yn I+V2hhdCBz ZXRzIEJhY2 hlbSBIb2xk aW5nIGFwYX J0IGZyb20g b3RoZXIgcG hhcm1hY2V1 dGljYWwgY2 9tcGFuaWVz IGlzIGl0cy B1bmlxdWUg ZXhwZXJ0aX NlIGluIHBl cHRpZGUgY2 hlbWlzdHJ5 IGFuZCBpdH MgY29tbWl0 bWVudCB0by Bpbm5vdmF0 aW9uIGFuZC Bjb250aW51 b3VzIGltcH JvdmVtZW50 IGluIGl0cy Bwcm9kdWN0 aW9uIHByb2 Nlc3Nlcy4g VGhlIGNvbX BhbnkgaW52 ZXN0cyBoZW F2aWx5IGlu IHJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudCB0byBj b25zdGFudG x5IGV4cGFu ZCBpdHMgcH JvZHVjdCBw b3J0Zm9saW 8gYW5kIGlt cHJvdmUgaX RzIHByb2R1 Y3Rpb24gY2 FwYWJpbGl0 aWVzLjxicj 5BZGRpdGlv bmFsbHksIE JhY2hlbSBI b2xkaW5nIG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBx dWFsaXR5IG FuZCByZWd1 bGF0b3J5IG NvbXBsaWFu Y2UsIGVuc3 VyaW5nIHRo YXQgaXRzIH Byb2R1Y3Rz IG1lZXQgdG hlIGhpZ2hl c3Qgc3Rhbm RhcmRzIG9m IHNhZmV0eS BhbmQgZWZm aWNhY3kuIF RoaXMgYXR0 ZW50aW9uIH RvIHF1YWxp dHkgaGFzIG Vhcm5lZCB0 aGUgY29tcG FueSBhIHN0 cm9uZyByZX B1dGF0aW9u IGFuZCB0cn VzdCBhbW9u ZyBjdXN0b2 1lcnMgYW5k IHJlZ3VsYX RvcnkgYm9k aWVzLjxicj 5GdXJ0aGVy bW9yZSwgQm FjaGVtIEhv bGRpbmcgb3 BlcmF0ZXMg aXRzIG93bi BtYW51ZmFj dHVyaW5nIG ZhY2lsaXRp ZXMsIGdpdm luZyBpdCBm dWxsIGNvbn Ryb2wgb3Zl ciB0aGUgcH JvZHVjdGlv biBwcm9jZX NzIGFuZCBh bGxvd2luZy Bmb3IgZWZm aWNpZW50IG FuZCBjb3N0 LWVmZmVjdG l2ZSBwcm9k dWN0aW9uLi BUaGlzIHZl cnRpY2FsIG ludGVncmF0 aW9uIGFsc2 8gYWxsb3dz IHRoZSBjb2 1wYW55IHRv IG9mZmVyIG N1c3RvbWl6 ZWQgc29sdX Rpb25zIGFu ZCBhIGhpZ2 ggbGV2ZWwg b2YgZmxleG liaWxpdHkg dG8gaXRzIG NsaWVudHMu PGJyPk92ZX JhbGwsIEJh Y2hlbSBIb2 xkaW5nJ3Mg Y29tYmluYX Rpb24gb2Yg ZXhwZXJ0aX NlLCBpbm5v dmF0aW9uLC BxdWFsaXR5 LCBhbmQgdm VydGljYWwg aW50ZWdyYX Rpb24gbWFr ZXMgaXQgYS BsZWFkaW5n IHBsYXllci BpbiB0aGUg cGhhcm1hY2 V1dGljYWwg aW5kdXN0cn kgYW5kIHNl dHMgaXQgYX BhcnQgZnJv bSBpdHMgY2 9tcGV0aXRv cnMu
What the company's business model?
Bachem Holding

πŸ“ˆ Want to read more about Bachem Holding?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

QmFjaGVtIE hvbGRpbmcg QUcgaXMgYS BTd2lzcyBw aGFybWFjZX V0aWNhbCBj b21wYW55IH RoYXQgc3Bl Y2lhbGl6ZX MgaW4gdGhl IGRldmVsb3 BtZW50IGFu ZCBwcm9kdW N0aW9uIG9m IHBlcHRpZG UtYmFzZWQg YWN0aXZlIH BoYXJtYWNl dXRpY2FsIG luZ3JlZGll bnRzIChBUE lzKSBhbmQg cGhhcm1hY2 V1dGljYWwg cHJvZHVjdH MuIFRoZSBj b21wYW55J3 MgYnVzaW5l c3MgbW9kZW wgY2FuIGJl IGRlc2NyaW JlZCBhcyBh IHZlcnRpY2 FsbHkgaW50 ZWdyYXRlZC Btb2RlbCwg YXMgaXQgY2 92ZXJzIHRo ZSBlbnRpcm UgdmFsdWUg Y2hhaW4gZn JvbSByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQgdG 8gY29tbWVy Y2lhbCBwcm 9kdWN0aW9u IGFuZCBzYW xlcyBvZiBp dHMgcHJvZH VjdHMuPGJy PkJhY2hlbS dzIGJ1c2lu ZXNzIG1vZG VsIHJldm9s dmVzIGFyb3 VuZCB0aHJl ZSBtYWluIG FyZWFzOiBj dXN0b20gc3 ludGhlc2lz LCBnZW5lcm ljIEFQSXMs IGFuZCBwaG FybWFjZXV0 aWNhbHMuID xicj4xLiBD dXN0b20gU3 ludGhlc2lz Ojxicj5CYW NoZW0ncyBj dXN0b20gc3 ludGhlc2lz IHNlcnZpY2 VzIGludm9s dmUgdGhlIG RldmVsb3Bt ZW50IGFuZC Bwcm9kdWN0 aW9uIG9mIH BlcHRpZGVz IGFuZCBvcm dhbmljIG1v bGVjdWxlcy BvbiBhIGNv bnRyYWN0IG Jhc2lzIGZv ciBwaGFybW FjZXV0aWNh bCBhbmQgYm lvdGVjaG5v bG9neSBjb2 1wYW5pZXMu IFRoaXMgaW 5jbHVkZXMg cHJvY2Vzcy BkZXZlbG9w bWVudCwgYW 5hbHl0aWNh bCBkZXZlbG 9wbWVudCwg YW5kIHNtYW xsIHRvIGxh cmdlLXNjYW xlIG1hbnVm YWN0dXJpbm cuIFRoZXNl IHNlcnZpY2 VzIGFyZSB0 YWlsb3JlZC B0byB0aGUg c3BlY2lmaW MgbmVlZHMg b2YgdGhlIG N1c3RvbWVy IGFuZCBjYW 4gY292ZXIg YSB3aWRlIH JhbmdlIG9m IHByb2R1Y3 RzLCBpbmNs dWRpbmcgZ2 VuZXJpYyBB UElzLCBhcy B3ZWxsIGFz IGlubm92YX RpdmUgYW5k IGNvbXBsZX ggcHJvZHVj dHMuPGJyPj IuIEdlbmVy aWMgQVBJcz o8YnI+QmFj aGVtIGFsc2 8gcHJvZHVj ZXMgYW5kIH N1cHBsaWVz IGdlbmVyaW MgQVBJcywg d2hpY2ggYX JlIGFjdGl2 ZSBpbmdyZW RpZW50cyB1 c2VkIGluIH RoZSBtYW51 ZmFjdHVyaW 5nIG9mIGdl bmVyaWMgZH J1Z3MuIFRo ZXNlIEFQSX MgYXJlIHBy b2R1Y2VkIG luIGxhcmdl IHF1YW50aX RpZXMgYW5k IHNvbGQgdG 8gcGhhcm1h Y2V1dGljYW wgY29tcGFu aWVzIHRoYX QgdXNlIHRo ZW0gYXMgdG hlIGJhc2lz IGZvciB0aG VpciBmaW5h bCBkcnVnIH Byb2R1Y3Rz LiBCYWNoZW 0ncyBnZW5l cmljIEFQSX MgYXJlIHVz ZWQgaW4gYS B2YXJpZXR5 IG9mIHRoZX JhcGV1dGlj IGFyZWFzLC BzdWNoIGFz IG9uY29sb2 d5LCBkaWFi ZXRlcywgYW 5kIGNhcmRp b3Zhc2N1bG FyIGRpc2Vh c2VzLjxicj 4zLiBQaGFy bWFjZXV0aW NhbHM6PGJy PkJhY2hlbS dzIHBoYXJt YWNldXRpY2 FsIGJ1c2lu ZXNzIGludm 9sdmVzIHRo ZSBkZXZlbG 9wbWVudCwg cHJvZHVjdG lvbiwgYW5k IGNvbW1lcm NpYWxpemF0 aW9uIG9mIG l0cyBvd24g cHJvcHJpZX RhcnkgZHJ1 Z3MuIFRoZS Bjb21wYW55 IGZvY3VzZX Mgb24gaW5u b3ZhdGl2ZS BwZXB0aWRl LWJhc2VkIH RoZXJhcGV1 dGljcyBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBkaXNl YXNlcyB3aX RoIGhpZ2gg dW5tZXQgbW VkaWNhbCBu ZWVkcywgc3 VjaCBhcyBt dWx0aXBsZS BzY2xlcm9z aXMsIGRpYW JldGVzLCBh bmQgaG9ybW 9uZS1yZWxh dGVkIGNhbm NlcnMuIEJh Y2hlbSBtYX JrZXRzIGl0 cyBwaGFybW FjZXV0aWNh bCBwcm9kdW N0cyB0aHJv dWdoIGl0cy Bvd24gc2Fs ZXMgZm9yY2 UgYW5kIGFs c28gY29sbG Fib3JhdGVz IHdpdGggcG hhcm1hY2V1 dGljYWwgY2 9tcGFuaWVz IGZvciBjby 1kZXZlbG9w bWVudCBhbm QgbGljZW5z aW5nIG9wcG 9ydHVuaXRp ZXMuPGJyPk 92ZXJhbGws IEJhY2hlbS dzIGJ1c2lu ZXNzIG1vZG VsIGlzIGNl bnRlcmVkIG Fyb3VuZCBp dHMgZXhwZX J0aXNlIGlu IHBlcHRpZG VzIGFuZCBv cmdhbmljIG 1vbGVjdWxl cywgYXMgd2 VsbCBhcyBp dHMgY2FwYW JpbGl0aWVz IGluIHByb2 Nlc3MgZGV2 ZWxvcG1lbn QgYW5kIGNv bW1lcmNpYW wgcHJvZHVj dGlvbi4gVG hlIGNvbXBh bnkncyB2ZX J0aWNhbGx5 IGludGVncm F0ZWQgYXBw cm9hY2ggYW xsb3dzIGl0 IHRvIG9mZm VyIGEgd2lk ZSByYW5nZS BvZiBzZXJ2 aWNlcyBhbm QgcHJvZHVj dHMsIGZyb2 0gY3VzdG9t IHN5bnRoZX NpcyB0byBn ZW5lcmljIE FQSXMgYW5k IHByb3ByaW V0YXJ5IHBo YXJtYWNldX RpY2Fscywg bWFraW5nIG l0IGEgbGVh ZGluZyBwbG F5ZXIgaW4g dGhlIGdsb2 JhbCBwZXB0 aWRlIG1hcm tldC4=
Is AI a threat?
To assess whether AI poses a material threat to Bachem Holding company’s products, services, or competitive positioning, we can analyze several aspects: substitution, disintermediation, and margin pressure.
1. Substitution: Bachem specializes in the development and manufacturing of peptides and related products for pharmaceutical and biotechnological applications. AI could potentially lead to the development of alternative methods or compounds that substitute for the peptides offered by Bachem. For example, advancements in synthetic biology or gene editing could provide alternatives to traditional peptide therapies. However, peptides have unique properties and applications, particularly in drug discovery and development, which are not easily substituted by AI-driven alternatives. Therefore, while there is a theoretical risk of substitution, the specificity and complexity of peptide-based products may limit this risk significantly.
2. Disintermediation: Disintermediation typically refers to the removal of intermediaries in supply chains or distribution channels, often facilitated by technology. In the case of Bachem, the company acts as a crucial supplier of specialized products to pharmaceutical firms. While AI could enhance manufacturing efficiency, it may not lead to disintermediation in the same way it could in other industries (e.g., retail). Bachem’s expertise in peptides requires significant scientific knowledge and technical skill, which may not be easily replicated or bypassed using AI. Thus, the risk of disintermediation appears limited in Bachem’s context.
3. Margin Pressure: AI has the potential to increase productivity and reduce costs across various sectors. For Bachem, the implementation of AI in research, development, and production processes may yield operational efficiencies, potentially leading to higher margins. However, if competitors adopt similar AI technologies, it could lead to increased competition, price reductions, or margin compression in the peptide market. Companies that can leverage AI to reduce their own costs while maintaining quality may exert pressure on Bachem’s pricing strategies. Therefore, while AI can enhance margins through efficiency, it may also lead to increased competition and potential margin pressure if not managed effectively.
In summary, while AI presents some risks in terms of substitution and margin pressure, the specific nature of Bachem’s products and services may limit these threats. Disintermediation seems unlikely due to the specialized expertise required in peptide manufacturing. Overall, Bachem may need to stay vigilant in adopting AI technologies to enhance its own offerings while monitoring competitive dynamics in its industry.
Sensitivity to interest rates
The sensitivity of Bachem Holding company’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Earnings Sensitivity: Bachem’s earnings could be affected by interest rate changes primarily through their impact on the cost of borrowing. If the company has existing debt, higher interest rates would increase interest expenses, potentially lowering net income. Conversely, if rates decrease, the cost of servicing debt could become cheaper, boosting earnings. Additionally, if interest rates rise, it may impact demand for Bachem’s products, as higher rates can lead to reduced capital expenditures by clients.
2. Cash Flow Sensitivity: Cash flows can also be affected by interest rates. Increased interest rates generally lead to higher financing costs and may strain the cash flow of companies that rely on debt financing for growth or operations. On the other hand, if Bachem operates with a healthy balance sheet and has minimal debt, the impact on cash flow may be less pronounced. Moreover, if higher rates hamper economic growth, this could lead to reduced demand for Bachem’s products, negatively impacting cash flow.
3. Valuation Sensitivity: The valuation of Bachem is often assessed through discounted cash flow (DCF) analysis, which factors in future cash flows discounted back to present value using an appropriate discount rate. As interest rates rise, the discount rate typically increases, which can result in a lower present value of future cash flows. This is particularly relevant in the context of long-term growth assumptions. If investors perceive higher rates as indicative of economic strain, they may also require a higher risk premium, further impacting valuation.
In summary, while Bachem’s earnings, cash flow, and valuation can be sensitive to changes in interest rates, the actual impact will depend on the company’s leverage, financial management, market conditions, and the broader economic environment.
Interesting facts about the company
Bachem Holding

πŸ“ˆ Want to read more about Bachem Holding?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvd2 E1bHJBa3hn SU83STZpVE p1ekMud2Vi cCIgYWx0PS JCYWNoZW0g SG9sZGluZy IgdGl0bGU9 IkJhY2hlbS BIb2xkaW5n IiAgY2xhc3 M9ImltZy1m bHVpZCIgaG VpZ2h0PTkw IHdpZHRoPT kwIGxvYWRp bmc9J2xhen knIHN0eWxl PSdib3JkZX ItcmFkaXVz OiA2cHg7Jz 4KCiAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nZmxl eDogMTsgdG V4dC1hbGln bjogY2VudG VyOyBtYXJn aW4tbGVmdD ogNXB4Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdmb2 50LXNpemU6 IDI2cHg7IG NvbG9yOiAj MzMzOyBtYX JnaW4tYm90 dG9tOiAxNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICDwn5OI IFdhbnQgdG 8gcmVhZCBt b3JlIGFib3 V0IEJhY2hl bSBIb2xkaW 5nPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+agC BEb27igJl0 IG1pc3MgPG k+IlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3MiPC9p PiDigJQgZn JlZSEKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9wPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx MnB4OyBmb2 50LXNpemU6 IDEzcHg7IG NvbG9yOiAj NDQ0Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIG5v dyBhbmQgZ2 V0IG91ciBm cmVlIGVCb2 9rIAogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGI+VGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2Nrczwv Yj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDE2cH g7IGZvbnQt c2l6ZTogMT RweDsgY29s b3I6ICM0ND Q7IGZvbnQt ZmFtaWx5Oi AtYXBwbGUt c3lzdGVtLC BCbGlua01h Y1N5c3RlbU ZvbnQsIFNl Z29lIFVJLC BSb2JvdG8s IEhlbHZldG ljYSBOZXVl LCBzYW5zLX NlcmlmOyBs aW5lLWhlaW dodDogMS42 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBIYXZlIH lvdSBoZWFy ZCBhYm91dC BvdXIgc2hv cnQgPHN0cm 9uZyBzdHls ZT0nZm9udC 13ZWlnaHQ6 IDYwMDsnPk RhaWx5IFZp ZGVvIE5ld3 NsZXR0ZXI8 L3N0cm9uZz 4/CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdodHRwcz ovL3d3dy5p bnNpZ2h0Zn VsdmFsdWUu Y29tL25ld3 NsZXR0ZXIu cGhwJyB0YX JnZXQ9J19i bGFuaycgc3 R5bGU9J2Nv bG9yOiAjMD A3QkZGOyB0 ZXh0LWRlY2 9yYXRpb246 IG5vbmU7IG ZvbnQtd2Vp Z2h0OiA1MD A7IG1hcmdp bi1sZWZ0Oi A2cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBGaW5kIG 91dCBtb3Jl CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2E+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgIC AgICAgICAt LT4KICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgCiAgICAg ICAgCiAgIC AgICAgPHNw YW4gY2xhc3 M9J2JsdXJy ZWQtdGV4dC c+CiAgICAg ICAgICAgIE 1TNGdRbUZq YUcgVnRJRW h2YkdScCBi bWNnUVVjZ2 FYIE1nWVNC VGQybHogY3 lCamIyMXdZ VyA1NUlIUm 9ZWFFnIGMz QmxZMmxoYk cgbDZaWE1n YVc0ZyBkR2 hsSUhCeWIy IFIxWTNScG IyNGcgYjJZ Z2NHVndkRy Bsa1pYTWdZ VzVrIElHTn ZiWEJzWlgg Z2diM0puWV c1cCBZeUJ0 YjJ4bFkzIF ZzWlhNZ1pt OXkgSUhCb1 lYSnRZVyBO bGRYUnBZMk ZzIElHRnVa Q0JpYVcgOT BaV05vSUhK bCBjMlZoY2 1Ob0xqIHhp Y2o0eUxpQl UgYUdVZ1ky OXRjRyBGdW VTQjNZWE1n IFptOTFibV JsWkMgQnBi aUF4T1RjeC BJR0o1SUZC bGRHIFZ5SU VkeWIyZG4g SUdGeklHRW djMyBCcGJp MXZabVlnIG IyWWdkR2hs SUggQm9ZWE p0WVdObCBk WFJwWTJGc0 lHIE52YlhC aGJua2cgVW 05amFHVXVQ RyBKeVBqTX VJRUpoIFky aGxiU0JJYj IgeGthVzVu SUVGSCBJR2 x6SUdobFlX IFJ4ZFdGeW RHVnkgWldR Z2FXNGdRbi BWaVpXNWti M0ptIExDQl RkMmwwZW0g VnliR0Z1Wk NCaCBibVFn YUdGeklIIE J5YjJSMVkz UnAgYjI0Z1 ptRmphVyB4 cGRHbGxjeU JwIGJpQkZk WEp2Y0cgVX NJSFJvWlNC ViBibWwwWl dRZ1UzIFJo ZEdWekxDQm ggYm1RZ1FY TnBZUyA0OF luSStOQzRn IFZHaGxJR0 52YlggQmhi bmtnWlcxdy BiRzk1Y3lC dmRtIFZ5SU RFc016QXcg SUhCbGIzQn NaUyBCM2Iz SnNaSGRwIF pHVWdZVzVr SUcgaGhjeU JoSUc1bCBk SGR2Y21zZ2 IyIFlnYzJG c1pYTWcgYj JabWFXTmxj eSBCcGJpQn RiM0psIElI Um9ZVzRnTk QgQWdZMjkx Ym5SeSBhV1 Z6TGp4aWNq IDQxTGlCQ1 lXTm8gWlcw Z1NHOXNaRy BsdVp5QkJS eUJwIGN5Qn NhWE4wWlcg UWdiMjRnZE dobCBJRk4z YVhOeklIIE 4wYjJOcklH VjQgWTJoaG JtZGxJRyBG dVpDQm9ZWE 1nIFlTQnRZ WEpyWlggUW dZMkZ3YVhS aCBiR2w2WV hScGIyIDRn YjJZZ2IzWm wgY2lBa01p NDFJRyBKcG JHeHBiMjR1 IFBHSnlQal l1SUYgUm9a U0JqYjIxdy BZVzU1NG9D WmN5IEJ3Y2 05a2RXTjAg Y3lCaGNtVW dkWCBObFpD Qm1iM0lnIG NtVnpaV0Z5 WTIgZ2dhVz RnWVhKbCBZ WE1nYzNWam FDIEJoY3lC allXNWogWl hJZ2RHaGxj bSBGd2VTd2 daR2xoIFlt VjBaWE1zSU cgRnVaQ0Jq WVhKayBhVz kyWVhOamRX IHhoY2lCa2 FYTmwgWVhO bGN5NDhZbi BJK055NGdR bUZqIGFHVn RJRWh2Ykcg UnBibWNnUV VjZyBhR0Z6 SUhCaGNuIF J1WlhKemFH bHcgY3lCaG JtUWdZMiA5 c2JHRmliM0 poIGRHbHZi bk1nZDIgbD BhQ0JzWldG ayBhVzVuSU hCb1lYIEp0 WVdObGRYUn AgWTJGc0lH RnVaQyBCaW FXOTBaV05v IElHTnZiWE JoYm0gbGxj eUJoY205MS BibVFnZEdo bElIIGR2Y2 14a0xqeGkg Y2o0NExpQk piaSBCaFpH UnBkR2x2IG JpQjBieUJw ZEggTWdZMj l5WlNCaSBk WE5wYm1Wem N5IEJ2WmlC d1pYQjAgYV dSbElIQnli MiBSMVkzUn BiMjRzIElI Um9aU0JqYj IgMXdZVzU1 SUdGcyBjMj hnYjJabVpY IEp6SUdOMW MzUnYgYlNC emVXNTBhRy BWemFYTXNJ SEJ5IGIyTm xjM01nWkcg VjJaV3h2Y0 cxbCBiblFz SUdGdVpDIE JoYm1Gc2VY UnAgWTJGc0 lITmxjbiBa cFkyVnpMan hpIGNqNDVM aUJDWVcgTm 9aVzBnU0c5 cyBaR2x1Wn lCQlJ5IEIz WVhNZ2RHaG wgSUdacGNu TjBJRyBOdm JYQmhibmtn IGFXNGdkR2 hsSUggZHZj bXhrSUhSdi BJSE41Ym5S b1pYIE5wZW 1VZ2FXNXog ZFd4cGJpQn BiaSBCc1lY Sm5aU0J4IG RXRnVkR2ww YVcgVnpMaU JVYUdseiBJ R0p5WldGcm RHIGh5YjNW bmFDQnMgWl dRZ2RHOGdj MiBsbmJtbG 1hV05oIGJu UWdZV1IyWV cgNWpaVzFs Ym5SeiBJR2 x1SUdScFlX IEpsZEdWek lIUnkgWldG MGJXVnVkQy A0OFluSStN VEF1IElGUm 9aU0JqYjIg MXdZVzU1SU doaCBjeUIz YjI0Z2JuIF Z0WlhKdmRY TWcgWVhkaG NtUnpJRyBa dmNpQnBkSE 1nIGFXNXVi M1poZEcgbH ZiaUJoYm1R ZyBZMjl1ZE hKcFluIFYw YVc5dWN5Qj AgYnlCMGFH VWdiRyBsbV pTQnpZMmxs IGJtTmxjeU JwYm0gUjFj M1J5ZVN3Zy BhVzVqYkhW a2FXIDVuSU hSb1pTQkMg WlhOMElFbH VibSA5MllY UnBiMjRnIF FYZGhjbVFn Wm4gSnZiU0 IwYUdVZyBS WFZ5YjNCbF lXIDRnVUdW d2RHbGsgWl NCVGVXMXdi MyBOcGRXMG dhVzRnIE1q QXhOaTQ9Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
Bachem Holding

πŸ“Š Get full analytics about Bachem Holding

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal